Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: Sept. 29, 2022‚Äč

'Bionic pancreas' could make life easier for people with type 1 diabetes. If approved by the FDA, the iLet Bionic Pancreas would be the most automated system...

Acute Respiratory Illness Due to EV-D68 Increased in Late Summer 2022

THURSDAY, Sept. 29, 2022 -- In late summer 2022, for children and adolescents, there was an increase in acute respiratory illness (ARI) resulting from...

Bionic Pancreas Bests Standard Care for Glycemic Control in T1DM

THURSDAY, Sept. 29, 2022 -- Reduction in glycated hemoglobin level is greater with use of a bionic pancreas compared with standard care in children and adults...

Perinatal Health Risks Increased in People With Disabilities

THURSDAY, Sept. 29, 2022 -- People reporting disabilities are more likely to have smoked during pregnancy and have an increased risk for preterm birth and low...

Pregnancy Anxiety May Predict Shorter Gestational Length

THURSDAY, Sept. 29, 2022 -- Pregnancy anxiety in the third trimester may predict shorter gestational length, according to a study published online in Health...

Periodontal Care May Help Improve Outcomes for Acute MI

THURSDAY, Sept. 29, 2022 -- Patients who receive periodontal care are significantly more likely to have follow-up visits after hospitalization for acute...

AHA News: For This Race Car Driver, Curing a Racing Heart Was Key to Crossing the Finish Line

THURSDAY, Sept. 29, 2022 (American Heart Association News) -- Bryce Cornet is no stranger to a racing heart. His heart beats faster each time he puts on his...

Healthy Living Boosts Life Span, Even for Former Smokers

THURSDAY, Sept. 29, 2022 -- Eating well and exercising can make for a longer life, and that holds true for former smokers, too, a new study shows. Researchers...

1 in 5 Young Women Has No Plans to Get a Mammogram

THURSDAY, Sept. 29, 2022 -- Terlisa Sheppard knows the value of tracking changes in her body. The Orlando Health patient was eight and a half months pregnant...

Hurricanes Threaten Many U.S. Coastal Hospitals With Serious Flooding

THURSDAY, Sept. 29, 2022 -- As Hurricane Ian slams Florida, a new study finds that many hospitals positioned near the Gulf and East Coasts are vulnerable to...

FDA Approves Vegzelma (bevacizumab-adcd), a Biosimilar to Avastin

Vegzelma is Celltrion’s third oncology biosimilar to receive approval from the U.S. FDA Vegzelma offers U.S. patients living with multiple types of...

FDA Approves Iheezo (chloroprocaine hydrochloride ophthalmic gel) for Ocular Surface Anesthesia

Iheezo Represents the First Approved Use in the U.S. Ophthalmic Market of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for...

FDA Approves Omlonti (omidenepag isopropyl ophthalmic solution) for Reduction of Elevated Intraocular Pressure in Primary Open-Angle Glaucoma or Ocular Hypertension

EMERYVILLE, Calif. & UBE, Japan--(BUSINESS WIRE) September 26, 2022 --Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE...

Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting

BOSTON--(BUSINESS WIRE)--Sep. 22, 2022-- Spectrum Pharmaceuticals (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical...

FDA Approves Pedmark (sodium thiosulfate injection) to Reduce Risk of Ototoxicity Associated with Cisplatin

Pedmark is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Ototoxicity Associated with Cisplatin in Pediatric Patients with...

Cidara Therapeutics Announces FDA Acceptance for Priority Review of New Drug Application for Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

Assigned PDUFA target action date of March 22, 2023 SAN DIEGO, Sept. 20, 2022 — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company...

FDA Approves Skysona (elivaldogene autotemcel) Gene Therapy for Early, Active Cerebral Adrenoleukodystrophy (CALD)

Skysona is the first FDA approved therapy shown to slow the progression of neurologic dysfunction in boys with this devastating and fatal neurodegenerative...

Acadia Pharmaceuticals Announces Trofinetide New Drug Application for the Treatment of Rett Syndrome has been Accepted for Filing and Review by U.S. FDA

NDA granted priority review Prescription Drug User Fee Act action date set for March 12, 2023 SAN DIEGO–(BUSINESS WIRE)–Sep. 12, 2022&ndash...

BioLineRx Announces Submission of New Drug Application (NDA) to FDA for Motixafortide in Stem Cell Mobilization

Submission based on overwhelmingly positive top-line results from GENESIS Phase 3 study Stem cell mobilization for bone marrow transplantation estimated to...

FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata

Filings based on clinical data demonstrating significant scalp hair regrowth versus placebo NEW YORK--(BUSINESS WIRE) September 09, 2022 -- Pfizer Inc...

Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib

LEIDEN, The Netherlands, Sept. 28, 2022.Pharming Group N.V. ("Pharming" or "the Company") announces that the US Food and Drug Administration (FDA) has accepted...

Bionic Pancreas Improves Type 1 Diabetes Management Compared to Standard Insulin Delivery Methods

September 28, 2022 -- A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at...

NIH Initiative to Systematically Investigate and Establish Function of Every Human Gene

September 27, 2022 -- The National Institutes of Health is launching a program to better understand the function of every human gene and generate a catalog of...

Study Confirms Link Between COVID-19 Vaccination and Temporary Increase in Menstrual Cycle Length

September 27, 2022 -- A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase...

First approval of TAAV synthetic DNA material for use in clinical trial

SAN SEBASTIAN, Spain, Sept. 27, 2022. TAAV Biomanufacturing Solutions, SL (TAAV) announced today the anticipated first use in a clinical trial of...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.